BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30307608)

  • 1. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
    Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
    Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn's syndrome.
    Tabori U; Mark Z; Amariglio N; Etzioni A; Golan H; Biloray B; Toren A; Rechavi G; Dalal I
    Clin Genet; 2004 Apr; 65(4):322-6. PubMed ID: 15025726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
    Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
    J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical and Genetic Spectrum of 82 Patients With
    Sharapova SO; Skomska-Pawliszak M; Rodina YA; Wolska-Kuśnierz B; Dabrowska-Leonik N; Mikołuć B; Pashchenko OE; Pasic S; Freiberger T; Milota T; Formánková R; Szaflarska A; Siedlar M; Avčin T; Markelj G; Ciznar P; Kalwak K; Kołtan S; Jackowska T; Drabko K; Gagro A; Pac M; Naumova E; Kandilarova S; Babol-Pokora K; Varabyou DS; Barendregt BH; Raykina EV; Varlamova TV; Pavlova AV; Grombirikova H; Debeljak M; Mersiyanova IV; Bondarenko AV; Chernyshova LI; Kostyuchenko LV; Guseva MN; Rascon J; Muleviciene A; Preiksaitiene E; Geier CB; Leiss-Piller A; Yamazaki Y; Kawai T; Walter JE; Kondratenko IV; Šedivá A; van der Burg M; Kuzmenko NB; Notarangelo LD; Bernatowska E; Aleinikova OV
    Front Immunol; 2020; 11():900. PubMed ID: 32655540
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
    Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
    Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
    Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
    BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mutations and recombination activity in RAG-deficient patients.
    Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
    Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
    Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
    Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan.
    Kato M; Kimura H; Seki M; Shimada A; Hayashi Y; Morio T; Kumaki S; Ishida Y; Kamachi Y; Yachie A
    Allergol Int; 2006 Jun; 55(2):115-9. PubMed ID: 17075247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The R229Q mutation of Rag2 does not characterize severe immunodeficiency in mice.
    Jin Y; Lee A; Oh JH; Lee HW; Ha SJ
    Sci Rep; 2019 Mar; 9(1):4415. PubMed ID: 30872621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
    Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
    Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding RAG deficiencies.
    Gennery A
    F1000Res; 2019; 8():. PubMed ID: 30800289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre.
    Karaatmaca B; Cagdas D; Esenboga S; Erman B; Tan C; Turul Ozgur T; Boztug K; van der Burg M; Sanal O; Tezcan I
    Clin Exp Immunol; 2024 Feb; 215(2):160-176. PubMed ID: 37724703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Omenn Syndrome Due to RAG2 Gene Mutation, a Case Report.
    Pourvali A; Arshi S; Nabavi M; Bemanian MH; Shokri S; Shahrooei M; Rezaei N; Fallahpour M
    Iran J Immunol; 2019 Dec; 16(4):334-338. PubMed ID: 31885011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel RAG1 mutation and the occurrence of mycobacterial and Chromobacterium violaceum infections in a case of leaky SCID.
    Khan TA; Iqbal A; Rahman H; Cabral-Marques O; Ishfaq M; Muhammad N
    Microb Pathog; 2017 Aug; 109():114-119. PubMed ID: 28552805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Manifestations, Mutational Analysis, and Immunological Phenotype in Patients with RAG1/2 Mutations: First Cases Series from Mexico and Description of Two Novel Mutations.
    Lugo-Reyes SO; Pastor N; González-Serrano E; Yamazaki-Nakashimada MA; Scheffler-Mendoza S; Berron-Ruiz L; Wakida G; Nuñez-Nuñez ME; Macias-Robles AP; Staines-Boone AT; Venegas-Montoya E; Alaez-Verson C; Molina-Garay C; Flores-Lagunes LL; Carrillo-Sanchez K; Niemela J; Rosenzweig SD; Gaytan P; Yañez JA; Martinez-Duncker I; Notarangelo LD; Espinosa-Padilla S; Cruz-Munoz ME
    J Clin Immunol; 2021 Aug; 41(6):1291-1302. PubMed ID: 33954879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.
    Dalal I; Tabori U; Bielorai B; Golan H; Rosenthal E; Amariglio N; Rechavi G; Toren A
    Clin Immunol; 2005 Apr; 115(1):70-3. PubMed ID: 15870023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational landscape of severe combined immunodeficiency patients from Turkey.
    Firtina S; Yin Ng Y; Hatirnaz Ng O; Kiykim A; Aydiner E; Nepesov S; Camcioglu Y; Sayar EH; Reisli I; Torun SH; Cogurlu T; Uygun D; Simsek IE; Kaya A; Cipe F; Cagdas D; Yucel E; Cekic S; Uygun V; Baris S; Ozen A; Ozbek U; Sayitoglu M
    Int J Immunogenet; 2020 Dec; 47(6):529-538. PubMed ID: 32445296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human RAG mutations: biochemistry and clinical implications.
    Notarangelo LD; Kim MS; Walter JE; Lee YN
    Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency.
    Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
    Ital J Pediatr; 2012 Mar; 38():8. PubMed ID: 22424479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.